Keyphrases
Peptidomimetics
100%
Solid Phase
100%
Thioether
100%
Agonist Activity
100%
Melanocortin Receptor Agonists
100%
Food Intake
50%
Potential Treatments
50%
Drug Target
50%
Melanocortin 1 Receptor (MC1R)
50%
Cysteine
50%
IC50 Value
50%
Peptide Bond
50%
I to
50%
Free Thiols
50%
Pharmacophore
50%
Solid-phase Synthesis
50%
Melanocortin 4 Receptor (MC4R)
50%
Intramolecular Reaction
50%
Skin pigmentation
50%
Melanocortin 5 Receptor
50%
Very High Purity
50%
Coat Coloration
50%
Thioether Bridge
50%
Obesity Treatment
50%
Biochemistry, Genetics and Molecular Biology
Peptidomimetic
100%
Receptor Agonists
100%
Thioether
100%
Melanocortin Receptor
100%
Agonist
66%
EC50
33%
Peptide Bond
33%
Pharmacophore
33%
Solid Phase Synthesis
33%
Skin Pigmentation
33%
Melanocortin 5 Receptor
33%
Melanocortin 1 Receptor
33%
Melanocortin 3 Receptor
33%
Arginine
33%
Thiol
33%
Cysteine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Melanocortin Receptor Agonist
100%
Thioether
100%
Peptidomimetics
100%
Cysteine
33%
Peptide Bond
33%
Arginine
33%
Melanocortin 3 Receptor
33%
Melanocortin 1 Receptor
33%
Melanocortin 5 Receptor
33%
EC50
33%
Thiol
33%
Chemistry
Melanocortin Receptor Agonist
100%
Peptidomimetic
100%
Drug Target
50%
Arg-Trp
50%
Melanocortin
50%
Thiol
50%
Cysteine
50%
EC50
50%